StonvexLoading…
StonvexStonvexStonvexCore line items from TGL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2024 2024-03-31 | Q4 2023 2023-12-31 | Q3 2023 2023-09-30 | Annual 2023 2023-06-30 |
|---|---|---|---|---|
Revenue | $21.77M | $20.18M | $13.46M | $69.41M |
Operating Income | $-4.38M | $-3.01M | $-1.92M | $-10.24M |
Net Income | $-5.04M | $-1.20M | $-2.13M | $-11.73M |
EPS (Diluted) | $-732.60 | $-8.30 | $-7.83 | $-49.18 |
Total Assets | $4.16M | $4.93M | $5.54M | $6.37M |
Total Liabilities | $1.09M | $1.24M | $6.48M | $6.50M |
Cash & Equivalents | $306.53K | $1.23M | $2.62M | $4.59M |
Free Cash Flow OCF − CapEx | $-4.18M | $-3.10M | $-1.90M | $-9.65M |
Shares Outstanding | 1.30M | 69.24M | 20.72M | 255.73K |